echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > NNN: The relationship between overweight/obesity in young adults and EBV infection in the etiology of multiple sclerosis

    NNN: The relationship between overweight/obesity in young adults and EBV infection in the etiology of multiple sclerosis

    • Last Update: 2021-09-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Purpose: Since obesity affects the immune response of cells to infection, our purpose is to investigate whether high body mass index (BMI) and high Epstein-Barr nuclear antigen 1 (EBNA-1) antibody levels are related to the risk of multiple sclerosis (MS)
    .


    We also aim to explore the aspects of BMI, Epstein-Barr virus (EBV) infection (high EBNA-1 antibody levels and history of infectious mononucleosis [IM], respectively) at the age of 20, and human leukocyte antigen (HLA)-DRB1* 15:01 Potential relationship between alleles


    Methods: A Swedish population-based case-control study (5460 cases and 7275 cases of control) was used to calculate the OR value (95% CIs) by logistic regression to evaluate overweight/obesity, IM history, EBNA-1 levels and HLA-DRB1 at the age of 20 *15:01 The relationship between MS risk
    .


    The potential interaction is evaluated on an additive scale


    Results: Compared with normal weight, there is a significant correlation between overweight/obesity and high (>50th percentile) EBNA-1 antibody levels (the ratio caused by the interaction is 0.
    2, 95% CI 0.
    1-0.
    4)
    .


    The higher the EBNA-1 antibody level, the stronger the interaction


    Table 1 The confidence interval for multiple sclerosis in subjects with different combinations of body mass index and EBNA-1 antibody levels at the age of 20 is 95%

    Table 1 The confidence interval for multiple sclerosis in subjects with different combinations of body mass index and EBNA-1 antibody levels at the age of 20 is 95%

    Table 2 The 95% CI of OR for subjects with different combinations of HLA-DRB1*15:01 status, 20-year-old BMI and IM medical history

    Table 2 The 95% CI of OR for subjects with different combinations of HLA-DRB1*15:01 status, 20-year-old BMI and IM medical history

    Figure HLA-DRB1*15:01, overweight/obesity (>25 kg/m 2 ), IM medical history and EBNA-1 status in different combinations of subjects compared with unexposed DRB1*15:01 negative subjects , The possibility of multiple sclerosis

    Figure HLA-DRB1*15:01, overweight/obesity (>25 kg/m 2 ), IM medical history and EBNA-1 status in different combinations of subjects compared with unexposed DRB1*15:01 negative subjects , The possibility of multiple sclerosis 2

    Conclusion: In terms of MS risk, the two aspects of overweight/obesity in young adults and EBV infection have a synergistic effect, especially in people who are genetically susceptible to the disease
    .


    Obesity can not only induce chronic immune-mediated inflammation, but also affect the cellular immune response to infection


    In terms of MS risk, the two aspects of overweight/obesity in young adults and EBV infection have a synergistic effect, especially in people who are genetically susceptible to the disease


    Hedström AK, Brenner N, Butt J,et al, Overweight/obesity in young adulthood interacts with aspects of EBV infection in MS etiology.


    Overweight/obesity in young adulthood interacts with aspects of EBV infection in MS etiology.
    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.